Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 Deals-lir 5 Industry Buzz: The 10 Biggest DX Mergers of 2019

Industry Buzz: The 10 Biggest DX Mergers of 2019

by | Jan 14, 2020 | Deals-lir, Industry Buzz-lir, Laboratory Industry Report

Conspicuous by its absence from the list is the proposed $1.2 billion Illumina takeover of Pacific Biosciences which suddenly seems to be in major trouble. Here are the 10-highest value M&A diagnostics deals that did come off in 2019.

Conspicuous by its absence from the list is the proposed $1.2 billion Illumina takeover of Pacific Biosciences which suddenly seems to be in major trouble. Here are the 10-highest value M&A diagnostics deals that did come off in 2019.

 

Top 10 Lab M&A Deals of 2019

RankBuyerTarget Reported Price
1DanaherGE Biopharma$21.4 billion
2Exact SciencesGenomic Health$2.8 billion (cash + stock)
3Thermo Fisher ScientificBrammer Bio$1.7 billion
4Agilent TechnologiesBioTek Instruments$1.17 billion
5PHC Holdings (formerly known as Panasonic Healthcare Holdings)Thermo Fisher Scientific$1.14 billion
6SartoriusDanaher$750 million*
7Covance Drug Development (part of LabCorp)Envigo$485 million
8Beckman Coulter Life SciencesLabcyte$308 million
9PerkinElmerCisbio Bioassays$219.8 million
10 Clayton, Dubilier & Rice investment fundsCynosure (owned by Hologic)$205 million

* Announced in 2019 with closing scheduled for 2020

Subscribe to view Essential

Start a Free Trial for immediate access to this article